-
Add to Cart The item has been addedH658721-5mgHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.Appearance:SolidIC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully -
Add to Cart The item has been addedH661586-1mlHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.IC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully suppresses the -
Add to Cart The item has been addedH649577-10mgHeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. HeE1-2Tyr significantly inhibits West Nile , Dengue and SARS-CoV-2 RdRps ( IC 50 of 27.6 µM) activity in vitroIn VitroHeE1-2Tyr shows -
Add to Cart The item has been addedH649577-25mgHeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. HeE1-2Tyr significantly inhibits West Nile , Dengue and SARS-CoV-2 RdRps ( IC 50 of 27.6 µM) activity in vitroIn VitroHeE1-2Tyr shows -
Add to Cart The item has been addedH649577-50mgHeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. HeE1-2Tyr significantly inhibits West Nile , Dengue and SARS-CoV-2 RdRps ( IC 50 of 27.6 µM) activity in vitroIn VitroHeE1-2Tyr shows -
Add to Cart The item has been addedH649577-5mgHeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. HeE1-2Tyr significantly inhibits West Nile , Dengue and SARS-CoV-2 RdRps ( IC 50 of 27.6 µM) activity in vitroIn VitroHeE1-2Tyr shows -
Add to Cart The item has been addedH655910-1mlHeE1-2Tyr, a pyridobenzothiazole compound, is a flavivirus RNA dependent RNA polymerases (RdRp) inhibitor. HeE1-2Tyr significantly inhibits West Nile , Dengue and SARS-CoV-2 RdRps ( IC 50 of 27.6 µM) activity in vitroIn VitroHeE1-2Tyr shows -
Add to Cart The item has been addedI649946-1mgIvermectin B1a, a derivative of Avermectin B1a ( HY-15308 ), is a main component of Ivermectin ( HY-15310 ). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .In -
Add to Cart The item has been addedI649946-5mgIvermectin B1a, a derivative of Avermectin B1a ( HY-15308 ), is a main component of Ivermectin ( HY-15310 ). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .In -
Add to Cart The item has been addedI656065-1mlIvermectin B1a, a derivative of Avermectin B1a ( HY-15308 ), is a main component of Ivermectin ( HY-15310 ). Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19 .In -
Add to Cart The item has been addedM651146-100mgMerafloxacin (CI-934), a fluoroquinolone antibacterial agent, is a selective programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of beta coronaviruses . Merafloxacin exhibits in vitro activity against gram-positive and gram-negative bacteriaIn -
Add to Cart The item has been addedM651146-10mgMerafloxacin (CI-934), a fluoroquinolone antibacterial agent, is a selective programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of beta coronaviruses . Merafloxacin exhibits in vitro activity against gram-positive and gram-negative bacteriaIn
